NCT04341025

Brief Summary

Erectile dysfunction (ED) is among the most common sexual dysfunctions experienced by men, affecting at least one third of men across the lifespan. Although pharmacological treatments are available, adherence to these treatments is poor, suggesting the need for integration of psychological interventions. This study will determine if a 6-session mindfulness-based psychosexual therapy (MBPST) group will be effective and feasible for men with situational ED. This study is adapted from a previously published 4-session MBPST protocol which was found to be beneficial for men with situational ED. Outcomes are measured using self-report questionnaires on sexual functioning/enjoyment, relationship satisfaction, and treatment acceptability.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 27, 2019

Completed
10 months until next milestone

First Posted

Study publicly available on registry

April 10, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

April 14, 2020

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

October 19, 2022

Status Verified

October 1, 2022

Enrollment Period

4.6 years

First QC Date

June 27, 2019

Last Update Submit

October 17, 2022

Conditions

Outcome Measures

Primary Outcomes (15)

  • Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5

    (IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire

    Change from baseline to immediately post treatment (6 weeks)

  • Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5

    (IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire

    Change from baseline to one month post-treatment (10 weeks)

  • Self-reported Erectile Functioning as measured by International Index of Erectile Function - 5

    (IIEF-5; Rosen, Cappelleri, Smith, Lipsky, \& Pena, 1999); 5 item questionnaire

    Change from baseline to four months post-treatment (22 weeks)

  • Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised

    (Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale

    Change from baseline to immediately post treatment (6 weeks)

  • Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised

    (Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale

    Change from baseline to one month post-treatment (10 weeks)

  • Self-reported Sexual Distress as measured by Sexual Distress Scale-Revised

    (Derogatis, Clayton, Lewis-D'Agostino, Wunderlich, \& Fu, 2008). This scale was recently validated for measuring sexual distress in men (Santos-Iglesias, Mohamed, Danko, \& Walker, 2018); 13 item rating scale

    Change from baseline to four months post-treatment (22 weeks)

  • Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning

    (Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale

    Change from baseline to immediately post treatment (6 weeks)

  • Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning

    (Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale

    Change from baseline to one month post-treatment (10 weeks)

  • Self-reported Confidence in Sexual and Erectile Competence as measured by Sexual Self-Efficacy Scale - Erectile Functioning

    (Fichten, Spector, Amsel, Creti, Brender, \& Libman, 1998), which measures confidence in sexual and erectile competence; 25 item rating scale

    Change from baseline to four months post-treatment (22 weeks)

  • Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale.

    (Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire

    Change from baseline to immediately post treatment (6 weeks)

  • Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale

    (Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire

    Change from baseline to one month post-treatment (10 weeks)

  • Self-reported Sexual Satisfaction and Pleasure as measured by International Index of Erectile Function - Overall Satisfaction Subscale

    (Rosen, Riley, Wagner, Osterloh, Kirkpatrick, \& Mishra, 1997), which measures sexual satisfaction. 2-item questionnaire

    Change from baseline to four months post-treatment (22 weeks)

  • Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire

    2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.

    Change from baseline to immediately post treatment (6 weeks)

  • Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire

    2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.

    Change from baseline to one month post-treatment (10 weeks)

  • Self-reported Sexual Pleasure as measured by an investigator-created Questionnaire

    2-item self report questionnaire on a 5-point scale assessing physical and emotional sexual pleasure.

    Change from baseline to four months post-treatment (22 weeks)

Secondary Outcomes (12)

  • Anxiety Symptoms as measured by Generalized Anxiety Disorder-7

    Change from baseline to immediately post treatment (6 weeks)

  • Anxiety Symptoms as measured by Generalized Anxiety Disorder-7

    Change from baseline to one month post-treatment (10 weeks)

  • Anxiety Symptoms as measured by Generalized Anxiety Disorder-7

    Change from baseline to four months post-treatment (22 weeks)

  • Degree of Mindfulness as measured by the Five Facet Mindfulness Questionnaire-15

    Change from baseline to immediately post treatment (6 weeks)

  • Degree of Mindfulness as measured by the Five Facet Mindfulness Questionnaire-15

    Change from baseline to one month post-treatment (10 weeks)

  • +7 more secondary outcomes

Other Outcomes (9)

  • Patient Satisfaction towards therapy group and Self-reported Impact on Quality of Sexual Life as measured by Patient Global Impression of Change Scale - Revised

    Change from baseline to immediately post treatment (6 weeks)

  • Patient Satisfaction towards therapy group and Self-reported Impact on Quality of Sexual Life as measured by Patient Global Impression of Change Scale - Revised

    Change from baseline to one month post-treatment (10 weeks)

  • Patient Satisfaction towards therapy group and Self-reported Impact on Quality of Sexual Life as measured by Patient Global Impression of Change Scale - Revised

    Change from baseline to four months post-treatment (22 weeks)

  • +6 more other outcomes

Study Arms (1)

Single Arm

OTHER

Patients are compared to themselves before and after the treatment.

Behavioral: Mindfulness based psychosexual therapy ( MBPST)

Interventions

The group treatment sessions will integrate empirically supported elements of psychoeduation, cognitive behavioural therapy, and mindfulness skills. Each of the six sessions will follow the well-defined manualized treatment protocol. The treatment is adapted from the study team's previous mindfulness-based treatment group (H15-03172), for situational ED which has been shown to be effective. Participants will be provided with handouts and asked to complete approximately 10-60 minutes/day of at-home practice/skills, which may include reading material, mindfulness exercises, and/or behavioural exercises between sessions. During the 2 follow-up sessions, participants will be invited to share their experience since the conclusion of group, ask questions, and participate in troubleshooting.

Also known as: MBCT ( Mindfulness based cognitive therapy )
Single Arm

Eligibility Criteria

Age19 Years+
Sexmale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • This study is open to individuals who are:
  • Diagnosed with situational erectile dysfunction (ED) of at least 6 months duration, as assessed by a physician at the BC Centre for Sexual Medicine according to DSM-5 criteria
  • years of age or older
  • Fluent enough in English to participate in group
  • Willing to abstain from using medications for ED (i.e., PDE5 inhibitors, intracavernosal injections, MUSE etc.) from the start of treatment until the 1-month follow-up (totaling 10 weeks)
  • Comfortable and interested in participating in a small group format with 6-10 others

You may not qualify if:

  • This study is not suitable for individuals who:
  • Do not experience an exacerbation of ED in the partnered context
  • Have a current unmanaged health condition (e.g., unmanaged diabetes mellitus) or unstable mental health condition (e.g., severe depression/anxiety, active suicidal ideation) that would interfere with self- or partnered-sexual activities or with group participation
  • Do no feel comfortable participating in a small group format with 6-10 others

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Vancouver General Hospital

Vancouver, British Columbia, V5Z 1M9, Canada

RECRUITING

Related Publications (1)

  • Bossio JA, Basson R, Driscoll M, Correia S, Brotto LA. Mindfulness-Based Group Therapy for Men With Situational Erectile Dysfunction: A Mixed-Methods Feasibility Analysis and Pilot Study. J Sex Med. 2018 Oct;15(10):1478-1490. doi: 10.1016/j.jsxm.2018.08.013.

MeSH Terms

Interventions

Mindfulness-Based Cognitive Therapy

Intervention Hierarchy (Ancestors)

MindfulnessCognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Miriam Driscoll, MD

    UBC

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shauna Correia, MD

CONTACT

Miriam Driscoll, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Participants will take part in a 6-session MBPST group for treatment of situational ED. Each session will be 2 hours in length and will be spaced one week apart, for a total of 12 hours of treatment time. Participants will also take part in supportive group follow-up sessions at 1- and 4-months following group completion. Treatment endpoints will be assessed at four time-points (pre-treatment, immediate post-treatment, 1-month post-treatment, and 4-months post-treatment).
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI

Study Record Dates

First Submitted

June 27, 2019

First Posted

April 10, 2020

Study Start

April 14, 2020

Primary Completion

December 1, 2024

Study Completion

December 1, 2024

Last Updated

October 19, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations